May 11 News - Annual report data shows that Lanhua Sci-Tech achieved revenue of RMB 8.142 billion in 2025, down 30.39% year-on-year; net profit attributable to parent was negative RMB 540 million, turning from profit to loss with a decline of 175.23%. Chempricehub's assessment of caprolactam: Bullish-bearish score: -1. As one of China's core producers of caprolactam, Lanhua Sci-Tech's shift from profit to loss in 2025 reflects the current profit pressure in the caprolactam industry, a loose supply-demand balance, a downward industry cycle, and a generally bearish impact on caprolactam prices.